Australia Blood-based Biomaker For Sports Medicine Market Size & Outlook
Australia blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Australia blood-based biomaker for sports medicine market highlights
- The Australia blood-based biomaker for sports medicine market generated a revenue of USD 21.7 million in 2023 and is expected to reach USD 39.7 million by 2030.
- The Australia market is expected to grow at a CAGR of 9% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 21.7 million |
| Market revenue in 2030 | USD 39.7 million |
| Growth rate | 9% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Australia accounted for 3.3% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 25.9 million by 2030.
Ck was the largest segment with a revenue share of 17.97% in 2023. Horizon Databook has segmented the Australia blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
Recent data highlights the growing focus on sports injury management in Australia. According to the Australian Institute of Health and Welfare’s September 2023 report, total health expenditure reached USD 195.4 billion, or about USD 7,764 per person, with USD 11.2 billion specifically allocated to sports injuries. This significant investment underscores the increasing priority given to athlete health and recovery.
In line with this trend, the market is expected to expand at a rapid pace in Australia. In addition, blood-based biomarkers offer valuable insights into injury risk, recovery progress, and overall athlete health, making them crucial for enhancing sports medicine practices. The demand for advanced diagnostic tools, including blood-based biomarkers, is expected to rise as the sports industry continues to grow.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Australia Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
